Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01486199 · ClinicalTrials.gov registry record · NA
Imaging Airway Liquid Absorption in Cystic Fibrosis
A NA study, sponsored by University of Pittsburgh.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT01486199 is a NA study that has completed, run by University of Pittsburgh. The registered enrollment target is 20 participants.
The verdict
NCT01486199, a NA study, has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
The investigators are developing a new nuclear medicine imaging technique for measuring liquid absorption in the airways that can be applied to screen new medications being developed to treat cystic fibrosis (CF). The investigators believe that the absorption of the small molecule radiopharmaceutical Indium 111-diethylenetriaminepentaacetic acid (In-DTPA) will indicate changes in liquid absorption in the airways and demonstrate whether new CF medications will be effective. In this study the investigators will further develop this technique through testing involving pediatric CF patients and healthy control subjects.
Interventions
- OTHER Absorptive clearance scan
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2011-10 |
| Est. Completion | 2014-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01486199
The ClinicalTrials.gov registry entry for NCT01486199 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Absorptive clearance scan is the first listed.
NCT01486199 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01486199 about?
NCT01486199 is a clinical study titled "Imaging Airway Liquid Absorption in Cystic Fibrosis". The investigators are developing a new nuclear medicine imaging technique for measuring liquid absorption in the airways that can be applied to screen new medications being developed to treat cystic fibrosis (CF). The investigators believe that the absorption of the small molecule radiopharmaceutica...
What is the current status of trial NCT01486199?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2011-10. Estimated completion is 2014-10.
What interventions are being tested in trial NCT01486199?
The interventions under investigation include: Absorptive clearance scan (OTHER).
Who is sponsoring clinical trial NCT01486199?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.